News
Approval was based on results from the Phase III ARANOTE trial, in which Nubeqa demonstrated a 46% reduction in the risk of ...
Airlines need to reach long-term agreements to buy bigger quantities of sustainable aviation fuel (SAF) if they want to boost global volumes of the lower-emissions fuel required for industry climate ...
FDA approves Bayer's Nubeqa with ADT for metastatic hormone-sensitive prostate cancer, cutting death risk by 46%. Read more ...
Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only Werner helicase (WRN) ...
Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently ...
Berlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for its oral androgen receptor inhibitor ...
Tufan Erginbilgiç's four pillars involved showing employees the extent of Rolls-Royce's issues, then giving them a say in ...
Former FC Freiburg Keeper Mark Flekken is officially back in the Bundesliga. Bayer Leverkusen confirmed the signing of the ...
LIfT BioSciences joins Bayer Co.Lab Cambridge, securing access to cutting-edge lab facilities London, 4 June 2025– LIfT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results